散発性疾患のコホートにおけるゲルムライン変異呼び出しツールの性能比較
Qiaofeng Song1, Jinglan Zhai1, Changshui Chen2
1Human Phenome Institute, MOE Key Laboratory of Contemporary Anthropology, Zhangjiang Fudan International Innovation Center, Fudan University, 825 Zhangheng Road, Shanghai, 201203, China.
Molecular genetics and genomics : MGG
|September 6, 2025
まとめ
DeepVariantとGATK HaplotypeCallerは,まれな疾患の変異の呼び出しに対して異なる強さを示しています. 適切なツールの選択は や自閉症のような 稀な症例の正確な遺伝子診断に 極めて重要です
科学分野:
- ゲノミクスとバイオインフォマティクス
- 珍しい 病気 の 遺伝
- 神経発達障害
背景:
- 次世代シーケンシング (NGS) を用いた稀有疾患の診断には,正確な変種呼び出しが不可欠です.
- 既存のベンチマークでは 細胞系やトリオが用いられていて 散発的な症例は反映されていません
- 偶発的な症例は や自閉症スペクトラム障害などの 珍しい疾患で一般的です
研究 の 目的:
- 中国の散発性と自閉症のコホートにおけるDeepVariantとGATK HaplotypeCallerのパフォーマンスを体系的に比較する.
- 病原性変異を特定するための変異呼び出しの有効性を評価する.
主な方法:
- DeepVariantとGATKハプロタイプキャラーの比較分析
- スポラディック・エピレプシー (EP) と自閉症スペクトラム障害 (ASD) の2人の中国人患者コホートを使用した.
- 病気に関連した遺伝子パネルでの分析された変異呼び出し性能.
主要な成果:
- DeepVariantは,単一ヌクレオチド変種 (SNV) に対して,より高い精度と感受性を示した.
- GATK HaplotypeCallerは 希少疾患の遺伝学にとって 極めて重要な 希少変異を特定することに 卓越しました
- 潜在的に有害な変種を検出する際の違いが2人の呼び出し者間で観察されました.
結論:
- 異なる呼び出しには異なるトレードオフがあり,文脈特有の戦略の選択が必要になります.
- 発芽変異の検出パイプラインを最適化することは,散発的な神経発達障害に不可欠です.
- 発見は 希少疾患の診断における 精密医療の 実践的な洞察を提供します
関連する概念動画
Comparing Copy Number Variations and SNPs
17.9K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.9K
Single Nucleotide Polymorphisms-SNPs
15.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.8K
Genetic Variation
387
Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles,...
Genes exist in different versions called alleles,...
387
Comparing the Survival Analysis of Two or More Groups
279
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
279
Genome-wide Association Studies-GWAS
14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.1K


